PetMed Express (PETS) Interim CEO Leslie C.G. Campbell Receives Award

What Happened
Leslie C.G. Campbell, Interim CEO and President and a Director of PetMed Express, received a grant of 60,000 shares on August 11, 2026. The Form 4 reports the transaction as an award (code A) at a $0.00 per-share price (typical for restricted stock grants), so the immediate cash value at grant is reported as $0.

Key Details

• Transaction date: 2026-08-11; filing date: 2026-08-13 (two days after the grant).
• Transaction type/code: Grant/award (A). Price reported: $0.00 per share. Total shares awarded: 60,000.
• Shares owned after the transaction: not specified in the information provided here.
• Footnote F1: These 60,000 shares are a restricted stock award under the PetMed Express, Inc. 2024 Omnibus Incentive Plan; they vest in full on the first anniversary of the grant date, subject to continued employment and accelerated vesting on death, disability, change of control, or certain terminations.
• Footnote F2: Separately notes certain shares are held in a family trust (spouse is trustee) and the reporting person disclaims beneficial ownership of those trust-held shares.

Context
This was a restricted stock award (compensation), not an open-market purchase or sale. Such awards are commonly used for retention and alignment with shareholders; they do not necessarily indicate an immediate cash investment by the insider. The filing appears timely (filed two days after the reported grant).